Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK–STAT pathway in Sézary syndrome
Sézary syndrome (SS) is an aggressive leukaemia of mature T cells with poor prognosis and limited options for targeted therapies. The comprehensive genetic alterations underlying the pathogenesis of SS are unknown. Here we integrate whole-genome sequencing (n=6), whole-exome sequencing (n=66) and ar...
Main Authors: | Kiel, Mark J., Sahasrabuddhe, Anagh A., Rolland, Delphine C. M., Velusamy, Thirunavukkarasu, Chung, Fuzon, Schaller, Matthew, Bailey, Nathanael G., Betz, Bryan L., Miranda, Roberto N., Porcu, Pierluigi, Byrd, John C., Jeffrey Medeiros, L., Kunkel, Steven L., Bahler, David W., Lim, Megan S., Elenitoba-Johnson, Kojo S. J. |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Pub. Group
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598843/ |
Similar Items
-
SIGNALING PATHWAYS AS BIOMARKERS
by: Sahasrabuddhe, Anagh A., et al.
Published: (2016) -
Alemtuzumab in refractory Sézary syndrome*
by: Reifs, Carmen María Alcántara, et al.
Published: (2016) -
Integrated Genomic Analysis of Sézary Syndrome
by: Mao, Xin, et al.
Published: (2011) -
BMI1: A Biomarker of Hematologic Malignancies
by: Sahasrabuddhe, Anagh A.
Published: (2016) -
Síndrome de Sèzary: relato de um caso
by: Marcelo Gil Cliquet, et al.
Published: (2016-10-01)